Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs
- PMID: 19592456
- DOI: 10.1099/vir.0.014480-0
Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs
Abstract
Influenza virus A/H1N1, which is currently causing a pandemic, contains gene segments with ancestors in the North American and Eurasian swine lineages. To get insights into virus replication dynamics, clinical symptoms and virus transmission in pigs, we infected animals intranasally with influenza virus A/Regensburg/D6/09/H1N1. Virus excretion in the inoculated pigs was detected in nasal swabs from 1 day post-infection (p.i.) onwards and the pigs developed generally mild symptoms, including fever, sneezing, nasal discharge and diarrhoea. Contact pigs became infected, shed virus and developed clinical symptoms similar to those in the inoculated animals. Plasma samples of all animals remained negative for virus RNA. Nucleoprotein- and haemagglutinin H1-specific antibodies could be detected by ELISA 7 days p.i. CD4(+) T cells became activated immediately after infection and both CD4(+) and CD8(+) T-cell populations expanded from 3 to 7 days p.i., coinciding with clinical signs. Contact chickens remained uninfected, as judged by the absence of virus excretion, clinical signs and seroconversion.
Similar articles
-
Challenge and polymorphism analysis of the novel A (H1N1) influenza virus to normal animals.Virus Res. 2010 Jul;151(1):60-5. doi: 10.1016/j.virusres.2010.03.019. Epub 2010 Apr 8. Virus Res. 2010. PMID: 20381552
-
[What is special about the new swine flu virus?].Pharm Unserer Zeit. 2009;38(6):488-90. doi: 10.1002/pauz.200990092. Pharm Unserer Zeit. 2009. PMID: 19862710 Review. German. No abstract available.
-
Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.Vaccine. 2009 Oct 23;27(45):6330-9. doi: 10.1016/j.vaccine.2009.03.021. Vaccine. 2009. PMID: 19840669
-
Evolutionary complexities of swine flu H1N1 gene sequences of 2009.Biochem Biophys Res Commun. 2009 Dec 18;390(3):349-51. doi: 10.1016/j.bbrc.2009.09.060. Epub 2009 Sep 19. Biochem Biophys Res Commun. 2009. PMID: 19769939 Review.
-
Pathogenesis and subsequent cross-protection of influenza virus infection in pigs sustained by an H1N2 strain.Zoonoses Public Health. 2010 Jun;57(4):273-80. doi: 10.1111/j.1863-2378.2009.01239.x. Epub 2009 Jun 17. Zoonoses Public Health. 2010. PMID: 19538454
Cited by
-
Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs.Vaccines (Basel). 2023 Nov 10;11(11):1707. doi: 10.3390/vaccines11111707. Vaccines (Basel). 2023. PMID: 38006039 Free PMC article.
-
Quantitative measurement of influenza virus transmission in animal model: an overview of current state.Biophys Rev. 2023 Sep 7;15(5):1359-1366. doi: 10.1007/s12551-023-01113-1. eCollection 2023 Oct. Biophys Rev. 2023. PMID: 37975001 Review.
-
Pathogen Exposure in White Whales (Delphinapterus leucas) in Svalbard, Norway.Pathogens. 2022 Dec 29;12(1):58. doi: 10.3390/pathogens12010058. Pathogens. 2022. PMID: 36678406 Free PMC article.
-
A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model.Front Immunol. 2022 Jul 7;13:915364. doi: 10.3389/fimmu.2022.915364. eCollection 2022. Front Immunol. 2022. PMID: 35874791 Free PMC article.
-
Animal Models Utilized for the Development of Influenza Virus Vaccines.Vaccines (Basel). 2021 Jul 14;9(7):787. doi: 10.3390/vaccines9070787. Vaccines (Basel). 2021. PMID: 34358203 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials